Burkina Faso vs Egypt: The number of people with susceptibility test result for rifampicin
Burkina Faso
3,042
in 2021
Egypt
2,962
in 2021
Burkina Faso rank
40th
Egypt rank
41st
The number of people with susceptibility test result for rifampicin over time
- Burkina Faso
- Egypt
How they compare
Burkina Faso currently reports 3,042 against 2,962 in Egypt, a difference of 80.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Burkina Faso ahead.
Burkina Faso ranks 40th and Egypt ranks 41st of 155 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Egypt in 1.
Head to head by decade
| Decade | Burkina Faso | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,230 | 2,475 | 1,245 | Egypt |
| 2020s | 3,162 | 2,888 | 273.5 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Burkina Faso or Egypt?
- Burkina Faso, at 3,042 against 2,962 in Egypt as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Burkina Faso and Egypt?
- 80, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Egypt?
- 5 years are reported by both, from 2017 to 2021.
- How do Burkina Faso and Egypt rank globally for the number of people with susceptibility test result for rifampicin?
- Burkina Faso ranks 40th and Egypt ranks 41st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.